Literature DB >> 14645141

Inhibition of human alpha 7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-D-aspartate receptors.

Peter D Maskell1, Pauline Speder, Nigel R Newberry, Isabel Bermudez.   

Abstract

1. Human alpha 7 nicotinic acetylcholine (ACh) receptors were expressed in Xenopus oocytes and the effects of the N-methyl-D-aspartate (NMDA) receptor open channel blockers memantine and cerestat on this receptor were examined using two-electrode voltage-clamp recordings and 125I-alpha-bungarotoxin (125I-alpha-bgtx) binding. 2. Memantine and cerestat produced complete inhibition of ACh-induced inward currents with affinities similar to that reported for native NMDA receptors. Cerestat, IC50 1.7 (-1; +2) microm, was more potent than memantine, IC50 5 (-3;+8) microM, and the effects of both drugs were fully and rapidly reversible. 3. Inhibition of alpha 7 receptor function was voltage-independent, and it occurred at concentrations far lower than those needed to inhibit (never completely) binding of 125I-alpha-bgtx to alpha 7 receptors, suggesting that the effects of memantine or cerestat are noncompetitive. 4. These results provide evidence that human alpha 7 receptors are inhibited by memantine and cerestat and suggest that caution should be applied when using these compounds to study systems in which NMDA and nACh receptors co-exist.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645141      PMCID: PMC1574144          DOI: 10.1038/sj.bjp.0705559

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors.

Authors:  M Zoli; M R Picciotto; R Ferrari; D Cocchi; J P Changeux
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

2.  The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner.

Authors:  G Rammes; R Rupprecht; U Ferrari; W Zieglgänsberger; C G Parsons
Journal:  Neurosci Lett       Date:  2001-06-22       Impact factor: 3.046

3.  Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function.

Authors:  J D Fryer; R J Lukas
Journal:  J Neurochem       Date:  1999-03       Impact factor: 5.372

4.  Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice.

Authors:  R E Ryan; S A Ross; J Drago; R E Loiacono
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

5.  Memantine inhibits efferent cholinergic transmission in the cochlea by blocking nicotinic acetylcholine receptors of outer hair cells.

Authors:  D Oliver; J Ludwig; E Reisinger; W Zoellner; J P Ruppersberg; B Fakler
Journal:  Mol Pharmacol       Date:  2001-07       Impact factor: 4.436

6.  Activity of cytisine and its brominated isosteres on recombinant human alpha7, alpha4beta2 and alpha4beta4 nicotinic acetylcholine receptors.

Authors:  L M Houlihan; Y Slater; D L Guerra; J H Peng; Y P Kuo; R J Lukas; B K Cassels; I Bermudez
Journal:  J Neurochem       Date:  2001-09       Impact factor: 5.372

7.  Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial.

Authors:  G W Albers; L B Goldstein; D Hall; L M Lesko
Journal:  JAMA       Date:  2001-12-05       Impact factor: 56.272

8.  Effects of diltiazem on human nicotinic acetylcholine and GABA(A) receptors.

Authors:  L M Houlihan; E Y Slater; D J Beadle; R J Lukas; I Bermudez
Journal:  Neuropharmacology       Date:  2000-10       Impact factor: 5.250

9.  The alpha7 nicotinic acetylcholine receptor subtype mediates nicotine protection against NMDA excitotoxicity in primary hippocampal cultures through a Ca(2+) dependent mechanism.

Authors:  F A Dajas-Bailador; P A Lima; S Wonnacott
Journal:  Neuropharmacology       Date:  2000-10       Impact factor: 5.250

10.  Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei.

Authors:  R Klink; A de Kerchove d'Exaerde ; M Zoli; J P Changeux
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

View more
  18 in total

1.  Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine.

Authors:  Shawn E Kotermanski; Jon W Johnson
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

2.  Effects of Mg2+ on recovery of NMDA receptors from inhibition by memantine and ketamine reveal properties of a second site.

Authors:  Nathan G Glasgow; Madeleine R Wilcox; Jon W Johnson
Journal:  Neuropharmacology       Date:  2018-05-12       Impact factor: 5.250

Review 3.  Therapeutics of Neurotransmitters in Alzheimer's Disease.

Authors:  Ramesh Kandimalla; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Total synthesis of pinnatoxins A and G and revision of the mode of action of pinnatoxin A.

Authors:  Romulo Araoz; Denis Servent; Jordi Molgó; Bogdan I Iorga; Carole Fruchart-Gaillard; Evelyne Benoit; Zhenhua Gu; Craig Stivala; Armen Zakarian
Journal:  J Am Chem Soc       Date:  2011-06-17       Impact factor: 15.419

5.  Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization.

Authors:  Nathan G Glasgow; Nadezhda V Povysheva; Andrea M Azofeifa; Jon W Johnson
Journal:  J Neurosci       Date:  2017-09-06       Impact factor: 6.167

Review 6.  Alzheimer's Disease Therapeutic Approaches.

Authors:  Maria Revi
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

7.  Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss.

Authors:  Maria Talantova; Sara Sanz-Blasco; Xiaofei Zhang; Peng Xia; Mohd Waseem Akhtar; Shu-ichi Okamoto; Gustavo Dziewczapolski; Tomohiro Nakamura; Gang Cao; Alexander E Pratt; Yeon-Joo Kang; Shichun Tu; Elena Molokanova; Scott R McKercher; Samuel Andrew Hires; Hagit Sason; David G Stouffer; Matthew W Buczynski; James P Solomon; Sarah Michael; Evan T Powers; Jeffery W Kelly; Amanda Roberts; Gary Tong; Traci Fang-Newmeyer; James Parker; Emily A Holland; Dongxian Zhang; Nobuki Nakanishi; H-S Vincent Chen; Herman Wolosker; Yuqiang Wang; Loren H Parsons; Rajesh Ambasudhan; Eliezer Masliah; Stephen F Heinemann; Juan C Piña-Crespo; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

8.  The uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist memantine prolongs spatial memory in a rat delayed radial-arm maze memory task.

Authors:  Laura E Wise; Aron H Lichtman
Journal:  Eur J Pharmacol       Date:  2007-08-03       Impact factor: 4.432

9.  Effects of nicotine on sensorimotor gating impairment induced by long-term treatment with neurotoxic NMDA antagonism.

Authors:  Bruce A Rasmussen; David C Perry; Jahn O'Neil; Kebreten F Manaye; Yousef Tizabi
Journal:  Neurotox Res       Date:  2008 May-Jun       Impact factor: 3.911

10.  Pharmacodynamics of memantine: an update.

Authors:  G Rammes; W Danysz; C G Parsons
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.